nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute Coronary Syndromes
|
|
|
2005 |
96 |
7S1 |
p. 104-106 3 p. |
artikel |
2 |
Acute Myocardial Infarction
|
|
|
2005 |
96 |
7S1 |
p. 55-66 12 p. |
artikel |
3 |
Angiogenesis, Myogenesis, and Cell Therapies
|
|
|
2005 |
96 |
7S1 |
p. 67-73 7 p. |
artikel |
4 |
Antithrombin Alternatives: Low Molecular Weight Heparins, Direct ANtithrombins, Xa Inhibitors and More
|
|
|
2005 |
96 |
7S1 |
p. 3-4 2 p. |
artikel |
5 |
Atheroablation, Thrombectomy and Distal Protection
|
|
|
2005 |
96 |
7S1 |
p. 74-78 5 p. |
artikel |
6 |
Bifurcation Lesions
|
|
|
2005 |
96 |
7S1 |
p. 79-83 5 p. |
artikel |
7 |
Cardiovascular Disease Risk Factors
|
|
|
2005 |
96 |
7S1 |
p. 107-114 8 p. |
artikel |
8 |
Cardiovascular Genetics, Genomics, and Proteomics
|
|
|
2005 |
96 |
7S1 |
p. 9-10 2 p. |
artikel |
9 |
Carotid Angiography and Intervention
|
|
|
2005 |
96 |
7S1 |
p. 84-88 5 p. |
artikel |
10 |
Chronic Total Occlusions
|
|
|
2005 |
96 |
7S1 |
p. 161-165 5 p. |
artikel |
11 |
Chronic Total Occlusions: Exploring the Final Frontier
|
|
|
2005 |
96 |
7S1 |
p. 37-38 2 p. |
artikel |
12 |
Contrast Nephropathy and Contrast Agents
|
|
|
2005 |
96 |
7S1 |
p. 115-118 4 p. |
artikel |
13 |
Coronary Intervention, Restenosis and Complications
|
|
|
2005 |
96 |
7S1 |
p. 119-127 9 p. |
artikel |
14 |
Coronary Stent Design and New Clinical Trial Insights
|
|
|
2005 |
96 |
7S1 |
p. 33-34 2 p. |
artikel |
15 |
Cutting Edge Strategies in Acute Coronary Syndrome and Acute Myocardial Infarction
|
|
|
2005 |
96 |
7S1 |
p. 47-48 2 p. |
artikel |
16 |
Diabetes and Cardiovascular Disease: Attacking the Epidemic
|
|
|
2005 |
96 |
7S1 |
p. 31-32 2 p. |
artikel |
17 |
Distal Protection and Thrombectomy Devises in the Coronary and Peripheral Circulations
|
|
|
2005 |
96 |
7S1 |
p. 5-6 2 p. |
artikel |
18 |
Drug ELuting Stent Complications
|
|
|
2005 |
96 |
7S1 |
p. 170-175 6 p. |
artikel |
19 |
Drug Eluting Stent Restenosis
|
|
|
2005 |
96 |
7S1 |
p. 186-191 6 p. |
artikel |
20 |
Drug Eluting Stents Comparisons
|
|
|
2005 |
96 |
7S1 |
p. 166-169 4 p. |
artikel |
21 |
Drug Eluting Stents I
|
|
|
2005 |
96 |
7S1 |
p. 128-134 7 p. |
artikel |
22 |
Drug Eluting Stents II
|
|
|
2005 |
96 |
7S1 |
p. 176-185 10 p. |
artikel |
23 |
Drug Eluting Stents in Diabetic Patients
|
|
|
2005 |
96 |
7S1 |
p. 135-139 5 p. |
artikel |
24 |
Drug-Eluting Stents “Next Generation” Basic Science Workshop
|
|
|
2005 |
96 |
7S1 |
p. 7-8 2 p. |
artikel |
25 |
Endovascular
|
|
|
2005 |
96 |
7S1 |
p. 17-20 4 p. |
artikel |
26 |
Endovascular Interventions
|
|
|
2005 |
96 |
7S1 |
p. 140-148 9 p. |
artikel |
27 |
EuroPCR Special Session: Interventional Insights from Europe
|
|
|
2005 |
96 |
7S1 |
p. 41-42 2 p. |
artikel |
28 |
Imaging and Physiology
|
|
|
2005 |
96 |
7S1 |
p. 192-200 9 p. |
artikel |
29 |
Innovative Devices and Futuristic Therapies
|
|
|
2005 |
96 |
7S1 |
p. 51-52 2 p. |
artikel |
30 |
Interventional Heart Failure: Recent Developments and New Directions
|
|
|
2005 |
96 |
7S1 |
p. 11-12 2 p. |
artikel |
31 |
Interventional Pathobiology: Insights and Clinical Implications
|
|
|
2005 |
96 |
7S1 |
p. 23-24 2 p. |
artikel |
32 |
Interventional Pharmacology
|
|
|
2005 |
96 |
7S1 |
p. 149-156 8 p. |
artikel |
33 |
Left Main Coronary Intervention
|
|
|
2005 |
96 |
7S1 |
p. 201-207 7 p. |
artikel |
34 |
Miscellaneous
|
|
|
2005 |
96 |
7S1 |
p. 157-160 4 p. |
artikel |
35 |
Molecular Cardiology II: Myocardial Regeneration and Repair
|
|
|
2005 |
96 |
7S1 |
p. 25-26 2 p. |
artikel |
36 |
Molecular Cardiology I: New Frontiers in Cardiovascular Angiogenesis
|
|
|
2005 |
96 |
7S1 |
p. 13-14 2 p. |
artikel |
37 |
New Drug Eluting Stents
|
|
|
2005 |
96 |
7S1 |
p. 208-211 4 p. |
artikel |
38 |
Optimal Dianosis and Therapy
|
|
|
2005 |
96 |
7S1 |
p. 1-2 2 p. |
artikel |
39 |
Plaque Modification and Debulking in the Drug-ELuting Stent Era: Atherectomy, Atherotomy, and Laser
|
|
|
2005 |
96 |
7S1 |
p. 35-36 2 p. |
artikel |
40 |
Platelet Inhibition II: New Insights into Glycoprotein IIb/IIIa Antagonist Utilization
|
|
|
2005 |
96 |
7S1 |
p. 29-30 2 p. |
artikel |
41 |
Platelet Inhibition I: New Insights into Aspirin and Thienopyridine Utilization
|
|
|
2005 |
96 |
7S1 |
p. 15-16 2 p. |
artikel |
42 |
Stent Design and Technologies
|
|
|
2005 |
96 |
7S1 |
p. 212-213 2 p. |
artikel |
43 |
Structural Heart Disease
|
|
|
2005 |
96 |
7S1 |
p. 89-94 6 p. |
artikel |
44 |
Structural Heart Disease: Diagnosis and Interventional Approaches
|
|
|
2005 |
96 |
7S1 |
p. 49-50 2 p. |
artikel |
45 |
The Drug-Eluting Stent Summit IV (A)
|
|
|
2005 |
96 |
7S1 |
p. 45-46 2 p. |
artikel |
46 |
The Drug-ELuting STent Summit IV (B)
|
|
|
2005 |
96 |
7S1 |
p. 53-54 2 p. |
artikel |
47 |
The 3rd SCA&I Imaging Symposium
|
|
|
2005 |
96 |
7S1 |
p. 21-22 2 p. |
artikel |
48 |
The 6th Annual Microvascular Reperfusion and Primary Angioplasty Sympsoium: Advancing the Frontiers of Acute Myocardial Infarction Therapy
|
|
|
2005 |
96 |
7S1 |
p. 27-28 2 p. |
artikel |
49 |
Translational Research: Migrating Therapeutic Discoveries from the Bench to Bedside
|
|
|
2005 |
96 |
7S1 |
p. 39-40 2 p. |
artikel |
50 |
Treatment of In-Stent Restenosis
|
|
|
2005 |
96 |
7S1 |
p. 95-98 4 p. |
artikel |
51 |
Valvular Heart Disease
|
|
|
2005 |
96 |
7S1 |
p. 99-100 2 p. |
artikel |
52 |
Vascular Access and Complications
|
|
|
2005 |
96 |
7S1 |
p. 101-103 3 p. |
artikel |
53 |
Vulnerable Plaque: Pathophysiology, Detection and Therapeutic Intervention
|
|
|
2005 |
96 |
7S1 |
p. 43-44 2 p. |
artikel |